Загрузка...
The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies
For patients with hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) or arrhythmogenic cardiomyopathy (ACM), screening for pathogenic variants has become standard clinical practice. Genetic cascade screening also allows the identification of relatives that carry the same mutation as the...
Сохранить в:
| Опубликовано в: : | Int J Mol Sci |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7998409/ https://ncbi.nlm.nih.gov/pubmed/33799487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22062955 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|